Search

Displaying all 2 results
  1. Indication

    Relapsed CD22-positive B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

    go.drugbank.com/conditions/DBCOND0165828
    Drugs: Inotuzumab ozogamicin
  2. Indication

    Refractory CD22-positive B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

    go.drugbank.com/conditions/DBCOND0165829
    Drugs: Inotuzumab ozogamicin